TrialJournal of bone and mineral metabolism2016

The role of serum osteoprotegerin and receptor-activator of nuclear factor-κB ligand in metabolic bone disease of women after obesity surgery.

José A Balsa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.